BMP4 levels are increased in NAFLD and negatively correlated with lipid deposition, liver injury, and inflammation in NASH; upregulated BMP4 expression may suppress NASH-related ferroptosis. This evidence concerns the gene BMP4 and metabolic dysfunction-associated steatohepatitis.